Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 4,926.8 million compared to INR 3,484.16 million a year ago. Revenue was INR 4,954.28 million compared to INR 3,554.31 million a year ago. Net income was INR 65.45 million compared to INR 65.14 million a year ago. Basic earnings per share from continuing operations was INR 2.72 compared to INR 2.79 a year ago. Diluted earnings per share from continuing operations was INR 2.72 compared to INR 2.79 a year ago.